Fundraising FoxLnctac
Chengdu, CN · 1 known investors
Find your way into Lnctac
Sign up to see every warm intro you have to Lnctac
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lnctac team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lingtaike Biotech develops nucleic acid drugs based on lncRNA, using its proprietary lncRNA-mediated targeting chimera technology (lncTAC) combined with the UNAST platform to target traditionally undruggable disease targets. The company focuses on drug discovery for unmet clinical needs in the lncRNA field.
Founders & leadership
宋
宋旭Professor / Founder
Investors · 1
Frequently asked questions
- What does Lnctac do?
- Lingtaike Biotech develops nucleic acid drugs based on lncRNA, using its proprietary lncRNA-mediated targeting chimera technology (lncTAC) combined with the UNAST platform to target traditionally undruggable disease targets. The company focuses on drug discovery for unmet clinical needs in the lncRNA field.
- Who founded Lnctac?
- Lnctac was founded by 宋旭.
- Who are Lnctac's investors?
- Lnctac's investors include Pan-Lin Capital.
- Where is Lnctac headquartered?
- Lnctac is headquartered in Chengdu, CN.